Late neonatal lupus erythematosus onset in a child born of a mother with primary Sjögren's syndrome

Annals of the Rheumatic Diseases

Volumn 63, Issue 11, 2004, Pages 1496-1497

  Manthorpe, R ^a,d   ASvensson ^b   Wirestrand, L E ^c  

^a Sjogren's Syndrome Research Centre   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c CENTRAL HOSPITAL   (Sweden)

^d House Doctors   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LA ANTIBODY; RO ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATRIOVENTRICULAR BLOCK; CASE REPORT; CONGENITAL HEART BLOCK; DARIER DISEASE; ERYTHEMA; FEMALE; FETUS; GESTATIONAL AGE; HUMAN; HYPOTROPHY; IMMUNOFLUORESCENCE; LUPUS ERYTHEMATOSUS; LYMPHOCYTIC INFILTRATION; MALE; MATERNAL DISEASE; NEONATAL LUPUS SYNDROME; NEWBORN; NEWBORN DISEASE; PRIORITY JOURNAL; SJOEGREN SYNDROME;

AGE OF ONSET; CHILD OF IMPAIRED PARENTS; FEMALE; FETAL DEATH; HEART BLOCK; HUMANS; INFANT, NEWBORN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, THIRD; SJOGREN'S SYNDROME;

EID: 7244252965     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2003.014944     Document Type: Article

References (12)

1. Neiman AR, Lee LA, Weston WL, Buyon JP. Cutaneous manifestations of neonatal lupus without heart block: characteristics of mothers and children enrolled in a national registry. J Pediatr 2000;137:674-80.
2. Weston WL, Morelli JG, Lee LA. The clinical spectrum of anti-Ro-positive cutaneous neonatal lupus erythematosus. J Am Acad Dermatol 1999;40:675-81.
3. Salomonsson S, Dörner T, Theander E, Bremme K, Larsson P, Wahren-Herlenius M. A serological marker for fetal risk of congenital heart block. Arthritis Rheum 2002;46:1233-41.
4. Tran HB, Gordon TP, Fisher T, Edwards K, Ulmer K, Beroukas D, et al. Failure of murine maternal Ro52 autoantibodies to deposit in normal fetal cardiac tissue suggests importance of local fetal milieu [abstract]. Arthritis Rheum 2002;46(suppl):S114.
5. Manthorpe T, Manthorpe R. The outcome of pregnancies of patients with primary Sjögren's syndrome. In: Machtey I, ed. Progress in rheumatology 1984;II:141-4.
6. Manthorpe T, Manthorpe R. Congenital complete heart block in children of mothers with primary Sjögren's syndrome. Lancet 1992;340:1359-60.
7. Tseng C-E, Buyon JP. Neonatal lupus syndromes. Rheum Dis Clin of North Am 1997;23:31-54.
8. Lee LA. Maternal autoantibodies and pregnancy. II: The neonatal lupus syndrome, Baillieres Clin Rheumatol 1997;4:69-84.
9. Oxholm P. Epithelial immunoglobulin deposits and Langerhans cells in patients with primary Sjögren's syndrome. Copenhagen, Denmark: Laegeforeningens forlag, 1989 (Thesis).
10. Silverman ED, Laxer RM. Neonatal lupus erythematosus. Rheum Dis Clin of North Am 1997;23:599-618.
11. Manthorpe R, Oxholm P, Prause JU, Schiødt M. The Copenhagen criteria for Sjögren's syndrome. Scand J Rheumatol 1986;61(suppl):19-21.
12. Vitoli C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus group. Ann Rheum Dis 2002;61:554-8.